September 28, 2007 - CardioDynamics said it received market clearance from the FDA for its new BioZ Impedance Cardiography (ICG) clinical parameters and electronic medical record (EMR) interface capability for its BioZ Dx System.
The BioZ Dx is the product of a co-development partnership between the company and Philips Medical Systems that leverages each company’s technology and expertise.
